Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
Author(s): Hermansen K, Kolotkin RL, Hammer M, Zdravkovic M, Matthews D
Affiliation(s): Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus, Denmark. kjelherm@rm.dk
Publication date & source: 2010-07, Prim Care Diabetes., 4(2):113-7. Epub 2010 May 4.
Publication type: Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Patient-reported outcomes for liraglutide or glimepiride on metformin were investigated. Patients' treatment satisfaction on liraglutide was higher than with metformin alone and comparable with glimepiride+metformin. Patients perceived lower frequency of hypoglycaemia than glimepiride+metformin and lower frequency of hyperglycaemia than metformin. Impact of weight on quality of life did not differ.
|